The present evidence summary of SARS-CoV-2 vaccine-associated liver injury: A rapid systematic review

por Li, Zheng, Hu, Yue, Jiang, Yunlan
Publicado 2023

Evolutionary biology of human hepatitis viruses

por Rasche, Andrea, Sander, Anna-Lena, Corman, Victor Max, Drexler, Jan Felix
Publicado 2019

Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications

por Li, Wenhui, Urban, Stephan
Publicado 2016

Convalescent plasma therapy for persistent hepatitis E virus infection

por Ankcorn, Michael, Gallacher, Jennifer, Ijaz, Samreen, Taha, Yusri, Harvala, Heli, Maclennan, Sheila, Thomson, Emma C., Davis, Chris, Singer, Joshua B., da Silva Filipe, Ana, Smollett, Katherine, Niebel, Marc, Semple, Malcolm G., Tedder, Richard S., McPherson, Stuart
Publicado 2019

Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology

por Fioravanti, Jessica, Di Lucia, Pietro, Magini, Diletta, Moalli, Federica, Boni, Carolina, Benechet, Alexandre Pierre, Fumagalli, Valeria, Inverso, Donato, Vecchi, Andrea, Fiocchi, Amleto, Wieland, Stefan, Purcell, Robert, Ferrari, Carlo, Chisari, Francis V., Guidotti, Luca G., Iannacone, Matteo
Publicado 2017

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

por Ji, Dong, Qin, Enqiang, Xu, Jing, Zhang, Dawei, Cheng, Gregory, Wang, Yudong, Lau, George
Publicado 2020

Management of patients with autoimmune liver disease during COVID-19 pandemic

por Lleo, Ana, Invernizzi, Pietro, Lohse, Ansgar W., Aghemo, Alessio, Carbone, Marco
Publicado 2020

Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury

por Qi, Xiaolong, Liu, Chuan, Jiang, Zicheng, Gu, Ye, Zhang, Guo, Shao, Chuxiao, Yue, Hongmei, Chen, Zhenhuai, Ma, Baoyi, Liu, Dengxiang, Zhang, Lin, Wang, Jitao, Xu, Dan, Lei, Junqiang, Li, Xun, Huang, Huihong, Wang, Yan, Liu, Hongyan, Yang, Jie, Pan, Hongqiu, Liu, Weiying, Wang, Wenjuan, Li, Fujian, Zou, Shengqiang, Zhang, Hongguang, Dong, Jiahong
Publicado 2020

The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication

por Foster, R.T., Ure, D.R., Trepanier, D.J., Gallay, P.
Publicado 2017

The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8(+) T cell activation

por Esser-Nobis, Katharina, Schmidt, Julia, Nitschke, Katja, Neumann-Haefelin, Christoph, Thimme, Robert, Lohmann, Volker
Publicado 2016

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity

por Shimura, Satomi, Watashi, Koichi, Fukano, Kento, Peel, Michael, Sluder, Ann, Kawai, Fumihiro, Iwamoto, Masashi, Tsukuda, Senko, Takeuchi, Junko S., Miyake, Takeshi, Sugiyama, Masaya, Ogasawara, Yuki, Park, Sam-Yong, Tanaka, Yasuhito, Kusuhara, Hiroyuki, Mizokami, Masashi, Sureau, Camille, Wakita, Takaji
Publicado 2017

NAFLD or comorbidities, that is the question

por Ponziani, Francesca Romana, Gasbarrini, Antonio, Pompili, Maurizio
Publicado 2020

No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease

por Biquard, Louise, Valla, Dominique, Rautou, Pierre-Emmanuel
Publicado 2020

The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care

por Tapper, Elliot B., Asrani, Sumeet K.
Publicado 2020

COVID-19: Abnormal liver function tests

por Cai, Qingxian, Huang, Deliang, Yu, Hong, Zhu, Zhibin, Xia, Zhang, Su, Yinan, Li, Zhiwei, Zhou, Guangde, Gou, Jizhou, Qu, Jiuxin, Sun, Yan, Liu, Yingxia, He, Qing, Chen, Jun, Liu, Lei, Xu, Lin
Publicado 2020

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis

por Zhou, Yu-Jie, Zheng, Kenneth I., Wang, Xiao-Bo, Yan, Hua-Dong, Sun, Qing-Feng, Pan, Ke-Hua, Wang, Ting-Yao, Ma, Hong-Lei, Chen, Yong-Ping, George, Jacob, Zheng, Ming-Hua
Publicado 2020

Clinical characteristics of COVID-19 patients with abnormal liver tests

por Chen, Peng, Zhou, Benhong
Publicado 2020

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”

por Cai, Qingxian, Chen, Jun
Publicado 2020

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

por Wang, Yijin, Liu, Shuhong, Liu, Hongyang, Li, Wei, Lin, Fang, Jiang, Lina, Li, Xi, Xu, Pengfei, Zhang, Lixin, Zhao, Lihua, Cao, Yun, Kang, Jiarui, Yang, Jianfa, Li, Ling, Liu, Xiaoyan, Li, Yan, Nie, Ruifang, Mu, Jinsong, Lu, Fengmin, Zhao, Shousong, Lu, Jiangyang, Zhao, Jingmin
Publicado 2020

Reply to: ‘Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis’

por Ji, Dong, Qin, Enqiang, Lau, George
Publicado 2020